467235-08-1Relevant articles and documents
INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES
-
Paragraph 00305-00307, (2021/12/28)
Provided herein are heteroaryl inhibitors of fibroblast growth factor receptor kinases, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
METALLOENZYME INHIBITOR COMPOUNDS
-
Page/Page column 48, (2020/07/25)
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
METALLOENZYME INHIBITOR COMPOUNDS
-
Paragraph 0512; 0513; 0514; 0515, (2018/07/29)
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
METALLOENZYME INHIBITOR COMPOUNDS
-
Paragraph 0343; 0344; 0345; 0346, (2018/07/29)
Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
Novel benzotriazoles anti-inflammatory compounds
-
, (2008/06/13)
The present invention relates to novel benzotriazoles of the formula I wherein Het is an optionally substituted 5-membered heterocycle containing one to two heteroatoms selected from nitrogen, sulfur and oxygen wherein at least one of said heteroatoms ato
Novel benzotriazoles anti-inflammatory compounds
-
Page 59, (2010/11/29)
The present invention relates to novel benzotriazoles of the formula I wherein Het is an optionally substituted 5-membered heterocycle containing one to two heteroatoms selected from nitrogen, sulfur and oxygen wherein at least one of said heteroatoms ato